Friday, June 12, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1098 of 1,261
  1. US 7138137

    Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 21, 2006 · Expires Nov 16, 2026

    granted
  2. US 7135611

    Compositions and methods for characterizing and regulating Wnt pathways

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 14, 2006 · Expires Nov 9, 2026

    granted
  3. US 7135303

    Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 14, 2006 · Expires Nov 9, 2026

    granted
  4. US 7135324

    Viral recombinases, related articles, and methods of use thereof

    UNIVERSITY OF CONNECTICUT · Granted Nov 14, 2006 · Expires Nov 9, 2026

    granted
  5. US 7135192

    Cationic lipid compositions targeting angiogenic endothelial cells

    The Regents of the University of California · Granted Nov 14, 2006 · Expires Nov 9, 2026

    granted
  6. US 7135176

    VMP-like sequences of pathogenic Borrelia

    The Board of Regents of the University of Texas System · Granted Nov 14, 2006 · Expires Nov 9, 2026

    granted
  7. US 7135490

    Method for the treatment of glomerulonephritis

    Takeda Pharmaceutical Company Limited · Granted Nov 14, 2006 · Expires Nov 9, 2026

    granted
  8. US 7135177

    Immunoliposomes that optimize internalization into target cells

    The Regents of the University of California · Granted Nov 14, 2006 · Expires Nov 9, 2026

    granted
  9. US 7135453

    Reagents and methods for smooth muscle therapies

    THE ARIZONA BOARD OF REGENTS · Granted Nov 14, 2006 · Expires Nov 9, 2026

    granted
  10. US 7132420

    Aspartic protease inhibitors

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 7, 2006 · Expires Nov 2, 2026

    granted
  11. US 7132271

    Methods for enhancing the production of viral vaccines in cell culture

    The Regents of the University of California · Granted Nov 7, 2006 · Expires Nov 2, 2026

    granted
  12. US 7132422

    Sodium channel modulators

    Theravance, Inc. · Granted Nov 7, 2006 · Expires Nov 2, 2026

    granted
  13. US 7132547

    Preventives/remedies for urinary disturbance

    Takeda Pharmaceutical Company Limited · Granted Nov 7, 2006 · Expires Nov 2, 2026

    granted
  14. US 7132454

    HEXIM1 as a suppressor of HIV replication and cardiac hypertrophy

    The Regents of the University of California · Granted Nov 7, 2006 · Expires Nov 2, 2026

    granted
  15. US 7132109

    Using heat shock proteins to increase immune response

    University of Connecticut Health Center · Granted Nov 7, 2006 · Expires Nov 2, 2026

    granted
  16. US 7132122

    Direct micro-patterning of lipid bilayers using UV light and selected uses thereof

    The Regents of the University of California · Granted Nov 7, 2006 · Expires Nov 2, 2026

    granted
  17. US 7132403

    Antihelminthic anthraquinones and method of use thereof

    The Regents of the University of California · Granted Nov 7, 2006 · Expires Nov 2, 2026

    granted
  18. US 7132102

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 7, 2006 · Expires Nov 2, 2026

    granted
  19. US 7132392

    Inhibition of cell motility and angiogenesis by inhibitors of Grb2-SH2-domain

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 7, 2006 · Expires Nov 2, 2026

    granted
  20. BR PI0414331

    método de destruição de bactéria numa área de tratamento do paciente e composição antimicrobiana de terapia fotodinámica

    CERAMOPTECL IND INC [US] · Granted Nov 7, 2006 · Expires Nov 2, 2026

    granted
  21. US 7129358

    Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 31, 2006 · Expires Oct 26, 2026

    granted
  22. US 7129342

    Infectious cDNA clone of GB virus B and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 31, 2006 · Expires Oct 26, 2026

    granted
  23. US 7128904

    Material containing metal ion ligand complex producing nitric oxide in contact with blood

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 31, 2006 · Expires Oct 26, 2026

    granted
  24. US 7129221

    6,11-bicyclic erythromycin derivatives

    Enanta Pharmaceuticals, Inc. · Granted Oct 31, 2006 · Expires Oct 26, 2026

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.